SCHEMBL15745501

SCHEMBL15745501

CCN(CCCCNc1c2ccc(Cl)cc2nc2ccc(OC)cc12)C1CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.63
▸ KMT2A Q03164 4/20 0.63
▸ TDP1 Q9NUW8 2/20 0.63
▸ MBNL1 Q9NR56 1/20 0.62
▸ ADORA2A P29274 1/20 0.59
▸ USP2 O75604 4/20 0.56
▸ TP53 P04637 3/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ CASP1 P29466 3/20 0.56
▸ CASP7 P55210 3/20 0.56
▸ HBB P68871 3/20 0.56
▸ HSD17B10 Q99714 3/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ CYP2D6 P10635 2/20 0.56
▸ TSHR P16473 2/20 0.56
▸ BRCA1 P38398 2/20 0.56
▸ HIF1A Q16665 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ PRNP P04156 1/20 0.56
▸ CHRM2 P08172 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15745507 0.89 MEN1 (0.65) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL15061283 0.85 USP2 (0.71) MEN1KMT2ATDP1MBNL1ADORA2A
Hydrochloric Acid SCHEMBL15061267 0.85 USP2 (0.73) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL15061237 0.85 USP2 (0.71) MEN1KMT2ATDP1MBNL1ADORA2A
Hydrochloric Acid SCHEMBL15061230 0.85 USP2 (0.73) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL1152794 0.85 USP2 (0.71) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL15745503 0.85 USP2 (0.61) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL7869225 0.85 MBNL1 (0.81) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL20091298 0.84 MBNL1 (0.71) MEN1KMT2ATDP1MBNL1ADORA2A
SCHEMBL1153515 0.84 MBNL1 (0.71) MEN1KMT2ATDP1MBNL1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544100-B2 Autophagy inhibitors TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2020-01-28 — — US disclosed
US-20170000784-A1 Autophagy Inhibitors VAN ANDEL RESEARCH INSTITUTE 2017-01-05 — — US disclosed
US-20170000784-A1 Autophagy Inhibitors VAN ANDEL RESEARCH INSTITUTE 2017-01-05 — — US disclosed
US-20160137607-A1 Autophagy Inhibitors VAN ANDEL RESEARCH INSTITUTE 2016-05-19 — — US disclosed
US-20160137607-A1 Autophagy Inhibitors VAN ANDEL RESEARCH INSTITUTE 2016-05-19 — — US disclosed
US-9221760-B2 Autophagy inhibitors VAN ANDEL RESEARCH INSTITUTE (US) 2015-12-29 — — US disclosed
US-9221760-B2 Autophagy inhibitors VAN ANDEL RESEARCH INSTITUTE (US) 2015-12-29 — — US disclosed
WO-2015085229-A1 AUTOPHAGY INHIBITORS VAN ANDEL RESEARCH INSTITUTE (US) 2015-06-11 — — WO disclosed
US-20140148451-A1 Autophagy Inhibitors TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2014-05-29 — — US disclosed
US-20140148451-A1 Autophagy Inhibitors TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2014-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544100-B2 Autophagy inhibitors BECN1, ATG7, SQSTM1 MEN1 3902/4885KMT2A 4239/4885TDP1 2388/4885
US-20170000784-A1 Autophagy Inhibitors BRAF, HRAS, NRAS MEN1 1533/4885KMT2A 399/4885TDP1 3621/4885
US-20140148451-A1 Autophagy Inhibitors BECN1, ATG7, SQSTM1 MEN1 3902/4885KMT2A 4239/4885TDP1 2388/4885
US-20160137607-A1 Autophagy Inhibitors BECN1, ATG7, SQSTM1 MEN1 3902/4885KMT2A 4239/4885TDP1 2388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback